These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1197 related items for PubMed ID: 22137354

  • 1. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR, TRACK-HD investigators.
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [Abstract] [Full Text] [Related]

  • 2. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR, TRACK-HD Investigators.
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [Abstract] [Full Text] [Related]

  • 3. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC, TRACK-HD Investigators.
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [Abstract] [Full Text] [Related]

  • 4. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
    Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC, TRACK-HD investigators.
    Lancet Neurol; 2009 Sep; 8(9):791-801. PubMed ID: 19646924
    [Abstract] [Full Text] [Related]

  • 5. Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
    Georgiou-Karistianis N, Poudel GR, Domínguez D JF, Langmaid R, Gray MA, Churchyard A, Chua P, Borowsky B, Egan GF, Stout JC.
    Brain Cogn; 2013 Oct; 83(1):80-91. PubMed ID: 23938592
    [Abstract] [Full Text] [Related]

  • 6. Elevated brain iron is independent from atrophy in Huntington's Disease.
    Dumas EM, Versluis MJ, van den Bogaard SJ, van Osch MJ, Hart EP, van Roon-Mom WM, van Buchem MA, Webb AG, van der Grond J, Roos RA, TRACK-HD investigators.
    Neuroimage; 2012 Jul 02; 61(3):558-64. PubMed ID: 22480728
    [Abstract] [Full Text] [Related]

  • 7. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
    van den Bogaard SJ, Dumas EM, Ferrarini L, Milles J, van Buchem MA, van der Grond J, Roos RA.
    J Neurol Sci; 2011 Aug 15; 307(1-2):60-8. PubMed ID: 21624624
    [Abstract] [Full Text] [Related]

  • 8. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM, van der Grond J, Hafkemeijer A, Rombouts SA, Roos RA.
    Neuroimage Clin; 2016 Aug 15; 12():806-814. PubMed ID: 27830113
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR, Stout JC, Domínguez D JF, Churchyard A, Chua P, Egan GF, Georgiou-Karistianis N.
    Neurobiol Dis; 2015 Feb 15; 74():406-12. PubMed ID: 25497085
    [Abstract] [Full Text] [Related]

  • 10. The potential of composite cognitive scores for tracking progression in Huntington's disease.
    Jones R, Stout JC, Labuschagne I, Say M, Justo D, Coleman A, Dumas EM, Hart E, Owen G, Durr A, Leavitt BR, Roos R, O'Regan A, Langbehn D, Tabrizi SJ, Frost C.
    J Huntingtons Dis; 2014 Feb 15; 3(2):197-207. PubMed ID: 25062862
    [Abstract] [Full Text] [Related]

  • 11. Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease.
    Hart EP, Dumas EM, Schoonderbeek A, Wolthuis SC, van Zwet EW, Roos RA.
    Mov Disord; 2014 Mar 15; 29(3):320-6. PubMed ID: 24500841
    [Abstract] [Full Text] [Related]

  • 12. Functional changes during working memory in Huntington's disease: 30-month longitudinal data from the IMAGE-HD study.
    Poudel GR, Stout JC, Domínguez DJ, Gray MA, Salmon L, Churchyard A, Chua P, Borowsky B, Egan GF, Georgiou-Karistianis N.
    Brain Struct Funct; 2015 Jan 15; 220(1):501-12. PubMed ID: 24240602
    [Abstract] [Full Text] [Related]

  • 13. Tapping linked to function and structure in premanifest and symptomatic Huntington disease.
    Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJ, Jauffret C, Say MJ, Sturrock A, Johnson H, Onorato CE, Salat DH, Durr A, Leavitt BR, Roos RA, Landwehrmeyer GB, Langbehn DR, Stout JC, Tabrizi SJ, Reilmann R.
    Neurology; 2010 Dec 14; 75(24):2150-60. PubMed ID: 21068430
    [Abstract] [Full Text] [Related]

  • 14. Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.
    Chen L, Hua J, Ross CA, Cai S, van Zijl PCM, Li X.
    J Neurosci Res; 2019 Apr 14; 97(4):467-479. PubMed ID: 30489648
    [Abstract] [Full Text] [Related]

  • 15. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study.
    Hobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI, Barnes J, Fox NC, Tabrizi SJ.
    J Neurol Neurosurg Psychiatry; 2010 Jul 14; 81(7):756-63. PubMed ID: 19955112
    [Abstract] [Full Text] [Related]

  • 16. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ, Seunarine KK, Gibbard CR, Hobbs NZ, Scahill RI, Clark CA, Tabrizi SJ.
    Cortex; 2014 Mar 14; 52():98-112. PubMed ID: 24405816
    [Abstract] [Full Text] [Related]

  • 17. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
    Reilmann R, Bohlen S, Klopstock T, Bender A, Weindl A, Saemann P, Auer DP, Ringelstein EB, Lange HW.
    Mov Disord; 2010 Oct 15; 25(13):2195-202. PubMed ID: 20645403
    [Abstract] [Full Text] [Related]

  • 18. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J.
    J Neurol Sci; 2005 Dec 15; 239(1):11-9. PubMed ID: 16185716
    [Abstract] [Full Text] [Related]

  • 19. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP, Dumas EM, Giltay EJ, Middelkoop HA, Roos RA.
    J Huntingtons Dis; 2013 Dec 15; 2(2):137-47. PubMed ID: 25063511
    [Abstract] [Full Text] [Related]

  • 20. Baseline multimodal information predicts future motor impairment in premanifest Huntington's disease.
    Castro E, Polosecki P, Rish I, Pustina D, Warner JH, Wood A, Sampaio C, Cecchi GA.
    Neuroimage Clin; 2018 Dec 15; 19():443-453. PubMed ID: 29984153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.